spacer
home > pmps > autumn 2017 > industry insight
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Industry Insight

Many of the manufacturing processes used for the production of medicines are pretty much the same today as they were when I began my professional career over 30 years ago. This is not necessarily due to a lack of advances in manufacturing technologies that could benefit the industry. To a large extent, the inertia for adopting alternative manufacturing technologies relates to the industry fearing rejection from the regulatory authorities for introducing such changes, which is unfounded. The value of the global pharmaceutical market is estimated to be worth over $500 billion annually, therefore improvements to manufacturing efficiencies could certainly pay dividends to companies in maximising the ‘profit’ to ‘cost of goods’ ratio.

Things are changing. The regulatory organisations are encouraging pharma manufacturers to invest in and exploit advanced manufacturing technologies, and the FDA has created the Emerging Technology Program to promote the adoption of innovative approaches to pharmaceutical product design and manufacturing (1,2).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Robert Harris, Chief Technical Officer at Juniper Pharma Services, PMPS Industry Advisor
spacer
Robert Harris
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Quanticate Partners with CluePoints to Offer Data Quality Oversight capabilities

Quanticate, a data-focused clinical research organisation (CRO), has announced that it has partnered with CluePoints as part of its new Data Quality Oversight service.
More info >>

White Papers

How to Reduce Costs of Specialty Pharmaceutical Shipments and Increase Patient Satisfaction

Temptime Corporation

The specialty pharmacy industry could reduce costs by $27.5 million annually (product and call center staff costs only) if visual temperature indicators were used as decision-making tools to determine if medicine should be used or returned when patients suspect heat damage. In addition, 97% of patients surveyed, who received medicine from specialty pharmacies with a visual temperature indicator included in the package, agree that they would want an indicator in all shipments and 95% agree the indicator increased their confidence in the medicines received.
More info >>

 
Industry Events

PDA Parenteral Packaging 2019

19-20 March 2019, Hilton Molino Stucky, Venice, Italy

PDA Europe’s Conference has become a must-attend event for all professionals in the Parenteral Packaging arena. Join us in Venice in March 2019 to continue and further deepen scientific advancements and our ongoing professional discourse of latest on primary packaging technologies and business trends. This conference and the accompanying exhibition address quality of components and cont­ainers, container closure development and integrity testing as well as aspects of processing, product distribution and storage.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement